Report Details:
15 Companies Covered
115 Pages
Pune, India, January, 2024/MRFR Press Release/- Market Research Future published a half cooked research report on the global microarrays analysis market.
Microarray Analysis Market Scenario
Microarray is an advanced molecular biology technique, used to spot expressions of many genes at the same time. Any abnormalities in gene functioning can lead to a critical disease. Microarrays serves a good platform for the diagnosis and development of treatment for this type of diseases. Microarray can be used for many micro molecules such as DNA, RNA, proteins, enzymes, carbohydrates, and tissues. Global microarray analysis market is majorly driven by the rapid development in the genetics, increasing prevalence of cancer and rising need of research. Increasing prevalence of chronic diseases, increasing healthcare expenditure and continuous development in the technology has propelled the market’s growth. However, high cost of the tests may slower this market’s growth.
The Microarray Analysis Market is expected to reach USD 5.3 Billion by 2032 at 7.24%CAGR during the forecast period 2024-2032
Segmentation
The global microarray analysis market is segmented into technology, consumables, services, application and end users.
On the basis of technology, the market is segmented into DNA microarray, PCR, NGS, SAGE, northern blotting and others.
On the basis of consumables, the market is segmented into DNA chips, DNA microarrays, protein microarrays, cellular microarrays, chemical compound microarrays, antibody microarrays and others. On the basis of services, the market is divided into gene profiling, bioinformatics and others.
On the basis of applications, the market is categorized into research, drug discovery, diagnostic and others.
Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Microarray Analysis Market Research Report
Regional Analysis
America accounts for the largest share in the global microarray analysis market owing to the presence of huge number of patients, high healthcare expenditure, and the increasing number of cancer patients. Europe is the second largest market in the global microarray analysis market due to increasing government’s support and the increasing geriatric population. Asia Pacific is the fastest growing market due to the presence of developing countries like India & China, and the presence of huge opportunities that will favor the growth of this market. However, the Middle East & Africa holds the least market share due to limited development in the healthcare sector.
Some of the key player among numerous players in this market are QIAGEN (Germany), Thermo Fisher Scientific, Inc. (US), Agilent Technologies (US), Applied Micro Arrays (US), Merck Sharp & Dohme Corp (US), Bio-Rad Laboratories, Inc. (US), PerkinElmer Inc. (US), Illumina, Inc. (US), Arrayit Corporation (US), BioGenex (US) and General Electric Company (UK).
The global microarrays analysis market is experiencing extreme competition as major companies are focusing on the development of the new and advance devices to overcome all disadvantages of available devices. Some of the leading players have adopted various strategies such as acquisitions and strategic alliances to grow in this market consequently leading to the growth of this market.
Qiagen, headquartered in Hilden, Germany, is a provider of sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Ingenuity Pathway Analysis is a web-based software that enables analysis, integration, and understanding of data from gene expression, miRNA, and SNP microarrays. It is one of the most successful product of this company.
Thermo Fisher Scientific, headquartered in the US, is an American multinational biotechnology product development company. This company manufacturers different devices, kits and instruments used for genetic testing. Axiom 2.0 Reagent Kit, PharmacoScan Assay Kit, Clariom D Pico Assay are some of the major kits used in the microarrays analysis method.